In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Something old, something new, something biobased: Designer grows a mushroom wedding gown
In the Netherlands, designer Dasha Tsapenko “grew” her wedding dress using mycelium and vintage linen lace sourced from Ukrainian flea markets.
“I wanted to combine...
Italy team develops biobased, inflammation-busting burn bandages
In Italy, a team from Istituto Italiano di Tecnologia has developed a biodegradable and biocompatible bandage using plant-based materials such as maize, pectin, and...
Swiss startup Nectariss recreates bougie fungi with fermentation
In Switzerland, a startup is recreating the intensely umami flavor of truffles, a pricey fungi that is impossible to cultivate and so difficult to...